Declaration of conformity
Home
Company Information
Press Releases
Investor Relations
Our Products
Our R&D
Searching
Company Information
Company Profile
Milestones
Company Culture
Awards & Honors
Production Facility
Contact Us
Press Releases
Investor Relations
Stock Information
Financial Information
Leadership & Governance
FAQ
Email Alert
Our Products
Protective Products
CNS Cerebral & Cardio Vascular
Anti-Viral/Infection & Respiratory
Digestive Diseases
Other
Health Product
Our R&D
In-house R&D
Cooperative R&D
Coperate Social Responsibility
Your position :
Home
>
Press Releases
Press Releases
Press Releases
Nov. 29, 2023_China Pharma Holdings, Inc. Announced the Completion of Third Part
2023-11-30
More details
Aug. 9, 2023_China Pharma’s Candesartan Hypertension Product Passes the Quality
2023-08-10
More details
Dec. 28, 2022_China Pharma Holdings, Inc. Announced the Launch of N95 Medical Pr
2022-12-28
More details
Dec. 15, 2022_China Pharma Holdings, Inc. Announced that several products are in
2022-12-16
More details
Dec. 5, 2022_China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Di
2022-12-05
More details
Mar. 31, 2022_China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Res
2022-03-31
More details
Nov. 12, 2021_China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial R
2021-11-13
More details
Aug. 13, 2021_China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial
2021-08-14
More details
MORE
1
2
3
4
5
Company Information
Company Profile
Milestones
Company Culture
Awards & Honors
Production Facility
Contact Us
Press Releases
Investor Relations
Stock Information
Financial Information
Leadership & Governance
FAQ
Email Alert
Our Products
Protective Products
CNS Cerebral & Cardio Vascular
Anti-Viral/Infection & Respiratory
Digestive Diseases
Other
Health Product
Our R&D
In-house R&D
Cooperative R&D
Coperate Social Responsibility
Contact Us
|
Company Profile
Copyright ©HAINAN HELPSON MEDICINE & BLOTECHNIQUE CO.,LTD All rights reserved
琼ICP备06001416号-2
SUPPORT BY:WWW.BUUGUU.COM